Search

everythinglearnresearchcommunity

for

Search:↓

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Aging skin shows thinner layers, fewer hair follicles, and new biomarkers like increased space between cells and smaller sebaceous glands.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Elephant tail-hair can show past stress levels, matching times when stressful events happened.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Stopping finasteride improves sperm quality but not semen volume in young men.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Hair restoration surgery can improve happiness, confidence, and social aspects of life, especially in younger patients with early hair loss.

Tofacitinib is an effective and safe treatment for alopecia areata.

Some medications can help increase sexual desire and function in women.

Some treatments like minoxidil, finasteride, and surgery can help with hereditary hair loss.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Testosterone increases muscle mass regardless of DHT conversion blocking.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

Certain sex hormones and antiandrogens can either slow down or speed up the growth of human hair follicle cells depending on their concentration.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.